Diffusion Pharmaceuticals Inc.

The momentum for this stock is not very good. Diffusion Pharmaceuticals Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Diffusion Pharmaceuticals Inc..

Diffusion Pharmaceuticals, Inc. is a clinical stage company which engages lead product candidate, tr...

News

Diffusion Pharmaceuticals (NASDAQ:DFFN) Now Covered by StockNews.com

Zolmax Equities research analysts at StockNews.com began coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN Free Report) in a note issued to investors on Friday. The firm set a hold rating on the stock. Diffusion Pharmaceuticals Stock Performance NASDAQ:DFFN opened at $3.34 on Friday. Diffusion ...\n more…

Diffusion Pharmaceuticals (NASDAQ:DFFN) Coverage Initiated by Analysts at StockNews.com

Zolmax StockNews.com initiated coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN Get Rating) in a report issued on Thursday. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Performance NASDAQ:DFFN opened at $3.55 on Thursday. Diffusion Pharmaceuticals has a 52 ...\n more…

Diffusion Pharmaceuticals (NASDAQ:DFFN) Coverage Initiated by Analysts at StockNews.com

Zolmax Stock analysts at StockNews.com initiated coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN Get Rating) in a report released on Wednesday. The brokerage set a hold rating on the stock. Diffusion Pharmaceuticals Stock Performance DFFN stock opened at $3.60 on ...\n more…

StockNews.com Begins Coverage on Diffusion Pharmaceuticals (NASDAQ:DFFN)

Zolmax StockNews.com initiated coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN Get Rating) in a research report released on Wednesday. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Performance Diffusion Pharmaceuticals stock opened at $3.60 on ...\n more…

Diffusion Pharmaceuticals (NASDAQ:DFFN) Coverage Initiated by Analysts at StockNews.com

Ticker Report StockNews.com began coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN Get Rating) in a research note issued to investors on Wednesday. The firm issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Up 2.4 % Shares of Diffusion Pharmaceuticals stock opened at $3.60 on ...\n more…

Diffusion Pharmaceuticals (NASDAQ:DFFN) Coverage Initiated at StockNews.com

Ticker Report Analysts at StockNews.com started coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN Get Rating) in a report issued on Tuesday. The firm set a hold rating on the stock. Diffusion Pharmaceuticals Trading Up 4.2 % NASDAQ:DFFN opened at $3.76 on Tuesday. The company has ...\n more…